Method for producing steviol synthetase gene and steviol
申请人:Yamaguchi Shinjiro
公开号:US20080271205A1
公开(公告)日:2008-10-30
To identify the steviol synthetase gene for research and development of metabolic engineering, for example, for increasing a stevioside producing ability. It was successfully found that CYP714A2 derived from
Arabidopsis thaliana
is surprisingly steviol synthetase. Furthermore, a system in which a large amount of steviol can be biosynthesized was developed by overexpressing this steviol synthetase gene. The steviol synthetase gene is, for example, a polynucleotide encoding a protein which includes the amino acid sequence of SEQ ID NO: 2.
INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARNT
申请人:UNIVERSITÀ DEGLI STUDI DI ROMA "LA SAPIENZA"
公开号:US20220259249A1
公开(公告)日:2022-08-18
The present invention relates to diterpene compounds of general formula (I) capable of contrasting the antibiotic-resistance mediated by the ArnT enzyme, to their use as a medicament, in particular for use as an adjuvant of an antibiotic therapy in the treatment of antibiotic-resistant bacterial infections. The invention relates also to associations of one or more of the compounds of formula (I) with at least another active ingredient, in particular an antibacterial agent and/or an antibiotic, and compositions comprising one or more compounds of formula (I) or the association according to the present invention and at least one pharmaceutically acceptable excipient and/or carrier as well as to products, in particular medical devices, comprising at least a compound, an association or a composition according to the present invention. Moreover, the invention relates to the use of compounds of formula (I) to sensitize a bacterium to an antibacterial agent or an antibiotic, for example, colistin (polymyxin E) or polymyxin B and to an in vivo or in vitro method for sensitizing a bacterium to an antibacterial agent or an antibiotic comprising the exposure of said bacterium to one or more compounds of formula (I) together with colistin.
[EN] RECOMBINANT MICROORGANISM FOR PRODUCING STEVIOL GLYCOSIDE<br/>[FR] MICRO-ORGANISME RECOMBINANT POUR LA PRODUCTION DE GLYCOSIDE DE STÉVIOL<br/>[KO] 스테비올 배당체 생산용 재조합 미생물
申请人:AJOU UNIV INDUSTRY-ACADEMIC COOPERATION FOUNDATION
公开号:WO2018012644A1
公开(公告)日:2018-01-18
본 발명은 스테비올 배당체 생산용 재조합 미생물 및 스테비올 배당체의 생산 방법에 관한 것이다. 본 발명의 스테비올 배당체 생산용 재조합 미생물은 스테비올모노사이드, 루부소사이드, 스테비올바이오사이드 또는 스테비오사이드를 다량으로 생산하는 우수한 효과가 있다. 따라서, 스테비아의 추출물로부터 직접 스테비올모노사이드, 루부소사이드, 스테비올바이오사이드 또는 스테비오사이드를 분리하는 것이 아닌, 미생물에 도입된 재조합 유전자에 의해 대사경로를 조작함으로써, 간단한 공정만으로도 스테비올모노사이드, 루부소사이드, 스테비올바이오사이드 또는 스테비오사이드를 경제적으로 생산할 수 있어, 상기 스테비올 배당체를 이용하는 천연 감미료 및 음료 등의 식품 산업에 유용하게 이용될 수 있다.